Article Information
History
- September 12, 2023.
Article Versions
- Version 1 (September 1, 2023 - 11:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Ana Karen Macias Alonso1,2,
- Julian Hirt2,3,4,
- Tim Woelfle2,5,
- Perrine Janiaud2,3 and
- Lars G. Hemkens2,3,6,7,*
- 1Department of Applied Natural Sciences, Technische Hochschule Lübeck, Lübeck, Germany
- 2Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland
- 3Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
- 4Institute of Nursing Science, Department of Health, Eastern Switzerland University of Applied Sciences, St. Gallen, Switzerland
- 5University Hospital Basel and University of Basel, Department of Neurology and MS Center, Basel, Switzerland
- 6Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, USA
- 7Meta-Research Innovation Center Berlin (METRIC-B), Berlin Institute of Health, Berlin, Germany
- ↵*Corresponding author
Lars G. Hemkens, MD, MPH, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Spitalstrasse 2, CH-4031 Basel, Switzerland, Phone: +41 61 265 3100, email: lars.hemkens{at}usb.ch